Croma-Pharma Acquires SynocromTM and Returns to Orthopaedics

AI Briefing

• – Croma-Pharma reacquires SynocromTM, a hyaluronic acid product for knee osteoarthritis treatment
• – Company returns to orthopaedics market after 2014 departure
• – Croma-Pharma broadens portfolio in field with strong historical roots